[Scripps Research] The National Institutes of Health (NIH) has awarded $16.4 million over five years to establish a new U19 “Cooperative Center for Rational hepatitis C virus Vaccine Design & Evaluation,” which will bring together scientists to uncover how the virus escapes immune responses and create vaccine candidates.

[Nature] An individual with cancer in France has become the first person known to contract the Shamonda virus, after an outbreak in livestock in Europe that was first identified in July 2026.

[Texas State University] Texas State University biologist Sumit Mukherjee, Ph.D., has secured a four-year, $752,000 grant, from the National Institute of Allergy and Infectious Diseases to uncover how malaria parasites build the structures that allow them to invade human red blood cells.

[Journal of Medical Virology] Scientists aimed to identify early predictive biomarkers, characterize their lead times, and develop a cumulative cytokine score for early risk stratification of COVID-19-associated cytokine storm.

[Scientific Reports] Researchers investigated sex differences among post-COVID-19 patients during the early recovery phase, as emerging evidence indicates that sex critically influences post-COVID-19 outcomes, particularly in older adults.

[Nature] Using proximity biotin labelling-based proteomics coupled with CRISPR–Cas9 validation, the authors identify nectin-4 as a functional rubella virus entry receptor.

[Cell] Investigators single-cell analysis revealed that viral replication requires a supra-unitary viral genome input, significantly more than one, which they defined as the virion input threshold for replication.

[Nature Microbiology] Using sequential exposure to the PltC form of typhoid toxin followed by oral Salmonella Typhi infection, scientists developed a mouse model of late-stage human typhoid, when circulating toxin precedes the onset of intestinal pathology.

[Journal of Medical Virology] Researchers investigated viral spatial distribution patterns and the corresponding lymphatic tissue structural alterations in simian immunodeficiency virus chronically infected rhesus macaques.

[Journal of Medical Virology] The authors investigated whether the SGLT2 inhibitor dapagliflozin could suppress BK polyomavirus replication, providing a strong rationale for evaluating SGLT2 inhibitors as a novel strategy to reduce the severity of infection in transplant recipients.

[Science Translational Medicine] Scientists conducted a phase I clinical trial with 45 healthy adults to test whether secondary infection challenge with a heterotypic, full-length, attenuated dengue virus increases viremia and immunogenicity compared with primary and tertiary infection.

[Science Advances] Researchers used human hair–bearing skin organoids and combined single-cell spatial transcriptomics with imaging to map herpes simplex virus 1 viral spread and host responses across skin architecture.